Patricia 'Patty' Obermaier is Executive Vice President and Chief Growth Officer at Acentra Health, where she leads business development, marketing, and product management for a technology and health solutions company serving government and commercial clients. A biology graduate of MIT with a Darden MBA, she spent the bulk of her career at Microsoft - most recently as Chief Growth Officer for Global Health and Life Sciences overseeing a $12 billion portfolio and helping integrate the $20 billion Nuance acquisition. Before that she doubled Microsoft's U.S. Health and Life Sciences business from $3 billion to $6 billion, founded the consultancy Resigility, and spent five-plus years as a senior executive at IQVIA. She sits on the boards of ASGN Incorporated and Applied Information Sciences and was named to Fierce Healthcare's 2021 Women of Influence.
Josh Rose is the CEO of Hawthorne Health, Inc. (formerly Hawthorne Effect), a Walnut Creek-based company building the largest community-based clinical trial site network in the U.S. A clinical research industry veteran with over 20 years of experience, Rose previously led decentralized clinical trial strategy at IQVIA and CVS Health before taking the helm at Hawthorne Health in early 2024. Under his leadership, Hawthorne has expanded to 75+ community locations, partnered with 40+ pharma sponsors, and pioneered a model that embeds certified clinical research staff inside independent pharmacies and patients' homes - bringing trials to communities that traditional research networks have long bypassed.